BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6099740)

  • 1. Tolerance and safety of enalapril.
    McFate Smith W; Davies RO; Gabriel MA; Kramsch DM; Moncloa F; Rush JE; Walker JF
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):249S-253S, 255S. PubMed ID: 6099740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of cross sensitivity between captopril and enalapril.
    Jackson B; Maher D; Matthews PG; McGrath BP; Johnston CI
    Aust N Z J Med; 1988 Feb; 18(1):21-7. PubMed ID: 2840055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enalapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Vlasses PH; Larijani GE; Conner DP; Ferguson RK
    Clin Pharm; 1985; 4(1):27-40. PubMed ID: 2982541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enalapril worldwide experience.
    Davies RO; Irvin JD; Kramsch DK; Walker JF; Moncloa F
    Am J Med; 1984 Aug; 77(2A):23-35. PubMed ID: 6089556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overall tolerance and safety of enalapril.
    McFate Smith W; Kulaga SF; Moncloa F; Pingeon R; Walker JF
    J Hypertens Suppl; 1984 Dec; 2(2):S113-7. PubMed ID: 6100872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors: past, present, and bright future.
    Edwards CR; Padfield PL
    Lancet; 1985 Jan; 1(8419):30-4. PubMed ID: 2856956
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.
    Kubo SH; Cody RJ
    Clin Pharmacokinet; 1985; 10(5):377-91. PubMed ID: 2994938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Captopril and enalapril: angiotensin converting enzyme (ACE) inhibitors.
    Ferguson RK; Vlasses PH; Riley LJ
    Ration Drug Ther; 1984 Mar; 18(3):1-5. PubMed ID: 6093192
    [No Abstract]   [Full Text] [Related]  

  • 9. [Worldwide experience with enalapril].
    Davies RO; Irvin JD; Kramsch DK; Walker JF; Moncloa F
    Presse Med; 1985 Dec; 14(44):2245-55. PubMed ID: 3003730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enalapril, a rash, and captopril.
    Kubo SH; Cody RJ
    Ann Intern Med; 1984 Apr; 100(4):616. PubMed ID: 6322634
    [No Abstract]   [Full Text] [Related]  

  • 11. A parallel study of enalapril and captopril and 1 year of experience with enalapril treatment in moderate-to-severe essential hypertension.
    Thind GS; Johnson A; Bhatnagar D; Henkel TW
    Am Heart J; 1985 Apr; 109(4):852-8. PubMed ID: 2984913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability of long term therapy with enalapril maleate in patients resistant to other therapies and intolerant to captopril.
    Rucinska EJ; Small R; Mulcahy WS; Snyder DL; Rodel PV; Rush JE; Smith RD; Walker JF; Irvin JD
    Med Toxicol Adverse Drug Exp; 1989; 4(2):144-52. PubMed ID: 2541310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview: the role of angiotensin-converting enzyme inhibitors in cardiovascular therapy.
    Abrams WB; Davies RO; Ferguson RK
    Fed Proc; 1984 Apr; 43(5):1314-21. PubMed ID: 6323221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resolution of captopril-induced rash after substitution of enalapril.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Pharmacotherapy; 1983; 3(2 Pt 1):131-3. PubMed ID: 6304662
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril.
    Irvin JD; Viau JM
    Am J Med; 1986 Oct; 81(4C):46-50. PubMed ID: 3022584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Angiotensin-converting enzyme inhibition: side effects and risks].
    Schilling H; Scheler F
    Z Kardiol; 1988; 77 Suppl 3():47-54. PubMed ID: 2850687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.
    DiBianco R
    Med Toxicol; 1986; 1(2):122-41. PubMed ID: 3023783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of captopril and enalapril in patients with severe chronic heart failure.
    Packer M; Lee WH; Yushak M; Medina N
    N Engl J Med; 1986 Oct; 315(14):847-53. PubMed ID: 3018566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.
    Todd PA; Heel RC
    Drugs; 1986 Mar; 31(3):198-248. PubMed ID: 3011386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of enalapril. Summing up the evidence.
    Dollery CT
    J Hypertens Suppl; 1983 Oct; 1(1):155-7. PubMed ID: 6100605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.